WO2024241250 - NOVEL COMPOSITION FOR TREATMENT OF INFLAMMATORY RELATED DISORDERS
National phase entry is expected:
Publication Number
WO/2024/241250
Publication Date
28.11.2024
International Application No.
PCT/IB2024/054991
International Filing Date
22.05.2024
Title **
[English]
NOVEL COMPOSITION FOR TREATMENT OF INFLAMMATORY RELATED DISORDERS
[French]
NOUVELLE COMPOSITION POUR LE TRAITEMENT DE TROUBLES INFLAMMATOIRES
Applicants **
VINOKUR, Vladimir
8 Zipornit Street
7171523 Modiin, IL
CHEVION, Dror
18 Hayahalom Street
4061818 Tel Mond, IL
ANGEL, Itzchak
22 Lotus Street
7404578 Nes Ziona, IL
Inventors
VINOKUR, Vladimir
8 Zipornit Street
7171523 Modiin, IL
CHEVION, Dror
18 Hayahalom Street
4061818 Tel Mond, IL
ANGEL, Itzchak
22 Lotus Street
7404578 Nes Ziona, IL
Priority Data
63/468,018
22.05.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1581 | |
| EPO | Filing, Examination | 6539 | |
| Japan | Filing | 531 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2205 |
Total: 11431 USD
Abstract[English]
or silver or gold or any combinations thereof, and a hydrophilic, non-ionic surfactant comprising polyethylene glycol (PEG) and a non-ionic triblock copolymer comprising poloxamers. The surfactant may further comprise nonionic triblock copolymers are composed of a central hydrophobic chain of polyoxypropylene (poly(propylene oxide)) flanked by two hydrophilic chains of polyoxyethylene (poly(ethylene oxide)). Also disclosed are procedures for the preparation of the complexes and pharmaceutical compositions comprising said complexes or any combinations of said complexes, as well as methods using the disclosed compositions and complexes in modulating cytokine levels in a subject and thereby treating inflammation-associated disorders.[French]
ou de l'argent ou de l'or ou toute combinaison associée, et un tensioactif non ionique hydrophile comprenant du polyéthylène glycol (PEG) et un copolymère triséquencé non ionique comprenant des poloxamères. Le tensioactif peut en outre comprendre des copolymères triséquencés non ioniques composés d'une chaîne hydrophobe centrale de polyoxypropylène (poly(oxyde de propylène)) flanquée de deux chaînes hydrophiles de polyoxyéthylène (poly(oxyde d'éthylène)). Sont également divulgués des procédures pour la préparation des complexes et des compositions pharmaceutiques comprenant lesdits complexes ou toute combinaison desdits complexes, ainsi que des procédés utilisant les compositions et les complexes divulgués dans la modulation de niveaux de cytokine chez un sujet, et ainsi dans le traitement de troubles inflammatoires.